NCS1 and Parkinson disease: Changes in NCS-1 expression will alter the relation with its target proteins and were described in a variety of diseases, including schizophrenia and Parkinson’s disease, both characterized by dysfunctional dopaminergic signaling (Koh et al., 2003; Kabbani et al., 2012; Dragicevic et al., 2014; Boeckel and Ehrlich, 2018; Bandura and Feng, 2019; Catoni et al., 2019).